Home
Journal Information
About
Aims and Scope
Contacts and Editorial Office
Editorial Board
Editor in Chief
Publisher
Conflicts of Interest
Editorial Policies
Publication Ethics
Nickan Research Institute policy
DISCLAIMER
Open Access
Journal Issues
Current Issue
In Press
Archive
Guidelines
For Authors
For Authors-New
For Reviewers
Peer Review Process in JRIP
Peer Review Process flowchart in JRIP
Authors agreement form
Checklist for review
Editorial Workflow
Publication Ethics and Malpractice Statement
Human and animal right
Informed Consent
Create Account
Login
Author
Title
Abstract
Keywords
First Name
Last Name
Search
eISSN
:
2345-2781
Submit Your Paper
Editorial Board
Aims and Scope
Publisher
Contact Us
Archive
Indexing Information
Member of
Follower of
2020, Vol 9, No. 3
×
Journal of Renal Injury Prevention
Journal Metrics
CiteScore (2019):
1.0
SNIP (2019):
0.623
IPP (2019):
0.65
SJR (2019):
0.217
H Index:
7
Chief Editor: Azar Baradaran
Original
1. The therapeutic efficnecy of ranolazine in comparison with conventional therapy in diabetic individuals with ischemic heart disease; a randomized clinical trial
Bahram Fariborz Farsad
, Seyed Mostafa Alavi*
, Golshid Ghorbanian, Fanak Fahimi, Zahra Ghaemmaghami, Ali Zahed Mehr, Hooman Bakhshandeh
J Renal Inj Prev
. 2020;9(1): e04.
doi:
10.15171/jrip.2020.04
Article
PDF
XML
Cited By:
0
×
The therapeutic efficnecy of ranolazine in comparison with conventional therapy in diabetic individuals with ischemic heart disease; a randomized clinical trial
